Table of Content

Executive Summary
Scope and Definition

1 Global Spatial Genomics and Transcriptomics Market: Overview
1.1 Market Overview
1.2 Regulatory Framework
1.2.1 U.S.
1.2.1.1 Regulatory Requirements for Products Intended as Medical Devices
1.2.1.2 Regulatory Requirements for Research Use Only (RUO) Products
1.2.2 European Union (EU)
1.2.2.1 Regulatory Requirements for Products Intended as Medical Devices
1.2.2.1.1 EU Medical Device Regulation
1.2.2.1.2 EU In Vitro Diagnostic Regulation
1.2.2.2 Regulatory Requirements for Sequencing Labs in the EU
1.2.3 Japan
1.2.3.1 Regulatory Requirements for Products Intended as Medical Devices
1.2.3.2 Regulatory Requirements in Japan
1.2.4 China
1.2.4.1 Regulatory Requirements for Products Intended as Medical Devices
1.3 Patent Analysis
1.3.1 Patent Filing Trend (by Country)
1.3.2 Patent Filing Trend (by Year)
1.3.3 Global Spatial Genomics and Transcriptomics Market, Supply Chain Analysis
1.3.4 Global Spatial Genomics and Transcriptomics Market, Value Chain Analysis
1.4 Market Dynamics Overview
1.4.1 Market Drivers
1.4.1.1 Increasing Use of Spatial Omics for Drug Discovery and Development
1.4.1.2 Technological Advancements in Sequencing
1.4.1.3 Increasing Research Funding in Spatial Transcriptomics
1.4.2 Market Restraints
1.4.2.1 High Capital Requirement Hampering the Global Reach
1.4.2.2 Lack of Skilled Professionals
1.4.3 Market Opportunities
1.4.3.1 Integration of Artificial Intelligence in Spatial Genomics and Transcriptomics

2 Global Spatial Genomics and Transcriptomics Market (by Product), $Million, 2022-2034
2.1 Kits and Assays
2.1.1 Sample Preparation Kits
2.1.2 Sample Enrichment Kits
2.2 Instrument
2.2.1 Slide Scanner
2.2.2 Microscopy
2.2.3 Mass Cytometry
2.3 Software
2.4 Services

3 Global Spatial Genomics and Transcriptomics Market (by Sample Type), $Million, 2022-2034
3.1 Fresh Frozen Tissues
3.2 Fixed Frozen Tissues
3.3 Formalin Fixed Paraffin Embedded (FFPE) Tissues
3.4 Cultured Cells

4 Global Spatial Genomics and Transcriptomics Market (by Workflow), $Million, 2022-2034
4.1 Spatial Imaging
4.1.1 Laser Capture Microdissection (LCM)
4.1.2 Immunohistochemistry (IHC)
4.1.3 Fluorescent In-Situ Hybridization (FISH) Cultured Cell
4.1.4 Microscopy
4.1.5 Barcodes
4.1.6 Other
4.2 Spatial Sequencing
4.2.1 Next-Generation Sequencing (NGS)
4.2.2 In-Vivo Transcription
4.2.3 Fluorescent In-Situ Sequencing (FISSEQ)
4.2.4 Microtomy Sequencing
4.2.5 Others
4.3 Spatial Analysis
4.3.1 Data Visualization Tools
4.3.2 Data Analysis Tools

5 Global Spatial Genomics and Transcriptomics Market (by Application), $Million, 2022-2034
5.1 Diagnostics
5.1.1 Cancer Diagnostics
5.1.2 Neurology Diagnostics
5.1.3 Immunology Diagnostics
5.1.4 Other Diagnostics
5.2 Drug Discovery and Development
5.3 Translational Research
5.4 Single Cell Analysis
5.5 Cell Biology
5.6 Other

6 Global Spatial Genomics and Transcriptomics Market (by End User), $Million, 2022-2034
6.1 Academic Institutes and Research Institutes
6.2 Biopharmaceutical and Biotechnology Companies
6.3 Contract Research Organization
6.4 Other End Users

7 Global Spatial Genomics and Transcriptomics Market (By Region), $Million, 2022-2034
7.1 North America
7.1.1 Regional Overview
7.1.2 Driving Factors for Market Growth
7.1.3 Factors Challenging the Market
7.1.3.1 U.S.
7.1.3.2 Canada
7.2 Europe
7.2.1 Regional Overview
7.2.2 Driving Factors for Market Growth
7.2.3 Factors Challenging the Market
7.2.3.1 Germany
7.2.3.2 U.K.
7.2.3.3 France
7.2.3.4 Italy
7.2.3.5 Spain
7.2.3.6 Rest-of-Europe
7.3 Asia-Pacific
7.3.1 Regional Overview
7.3.2 Driving Factors for Market Growth
7.3.3 Factors Challenging the Market
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia
7.3.3.5 Singapore
7.3.3.6 Rest-of-Asia-Pacific
7.4 Latin America
7.4.1 Regional Overview
7.4.2 Driving Factors for Market Growth
7.4.3 Factors Challenging the Market
7.4.3.1 Brazil
7.4.3.2 Mexico
7.4.3.3 Rest-of-Latin America
7.5 Middle East and Africa
7.5.1 Regional Overview
7.5.2 Driving Factors for Market Growth
7.5.3 Factors Challenging the Market

8 Competitive Insights and Company Profiles
8.1 Key Strategies and Development
8.1.1 Synergistic Activities
8.1.2 Funding and Expansion
8.1.3 Mergers and Acquisitions
8.1.4 Funding Activities
8.1.5 Service/Product Launches
8.2 Company Profiles
8.2.1 10x Genomics.
8.2.1.1 Overview
8.2.1.2 Top Products
8.2.1.3 Top Competitors
8.2.1.4 Target Customers/End Users
8.2.1.5 Analyst View
8.2.2 Akoya Biosciences, Inc.
8.2.2.1 Overview
8.2.2.2 Top Products
8.2.2.3 Top Competitors
8.2.2.4 Target Customers/End Users
8.2.2.5 Analyst View
8.2.3 Bruker Corporation
8.2.3.1 Overview
8.2.3.2 Top Products
8.2.3.3 Top Competitors
8.2.3.4 Target Customers/End Users
8.2.3.5 Analyst View
8.2.4 Bio-Techne.
8.2.4.1 Overview
8.2.4.2 Products Offered
8.2.4.3 Top Competitors
8.2.4.4 Target Customers/End Users
8.2.4.5 Analyst View
8.2.5 BioSpyder, Inc.
8.2.5.1 Overview
8.2.5.2 Top Products
8.2.5.3 Top Competitors
8.2.5.4 Target Customers/End Users
8.2.5.5 Analyst View
8.2.6 Flagship Biosciences, Inc.
8.2.6.1 Overview
8.2.6.2 Products Offered
8.2.6.3 Top Competitors
8.2.6.4 Target Customers/End Users
8.2.6.5 Analyst View
8.2.7 Illumina, Inc.
8.2.7.1 Overview
8.2.7.2 Top Products
8.2.7.3 Top Competitors
8.2.7.4 Target Customers/End Users
8.2.7.5 Analyst View
8.2.8 Miltenyi Biotec
8.2.8.1 Overview
8.2.8.2 Products Offered
8.2.8.3 Top Competitors
8.2.8.4 Target Customers/End Users
8.2.8.5 Analyst View
8.2.9 MGI Tech Co., Ltd.
8.2.9.1 Overview
8.2.9.2 Top Products
8.2.9.3 Top Competitors
8.2.9.4 Target Customers/End Users
8.2.9.5 Analyst View
8.2.10 RareCyte, Inc.
8.2.10.1 Overview
8.2.10.2 Products Offered
8.2.10.3 Top Competitors
8.2.10.4 Target Customers/End Users
8.2.10.5 Analyst View
8.2.11 Revvity, Inc.
8.2.11.1 Overview
8.2.11.2 Top Products and Services
8.2.11.3 Top Competitors
8.2.11.4 Analyst View
8.2.12 S2 Genomics, Inc.
8.2.12.1 Overview
8.2.12.2 Top Products
8.2.12.3 Top Competitors
8.2.12.4 Target Customers/End Users
8.2.12.5 Analyst View
8.2.13 Standard BioTools
8.2.13.1 Overview
8.2.13.2 Product Offered
8.2.13.3 Top Competitors
8.2.13.4 Target Customers/End Users
8.2.13.5 Analyst View
8.2.14 TissueGnostics GmbH
8.2.14.1 Overview
8.2.14.2 Top Products
8.2.14.3 Top Competitors
8.2.14.4 Target Customers/End Users
8.2.14.5 Analyst View
8.2.15 Vizgen Inc.
8.2.15.1 Overview
8.2.15.2 Services Offered
8.2.15.3 Top Competitors
8.2.15.4 Target Customers/End Users
8.2.15.5 Analyst View

9 Research Methodology
9.1 Data Sources
9.1.1 Primary Data Sources
9.1.2 Secondary Data Sources
9.1.3 Data Triangulation
9.2 Market Estimation and Forecast

List of Figures
Figure 1: Global Spatial Genomics and Transcriptomics Market, $Million, 2024, 2028, and 2034
Figure 2: Global Spatial Genomics and Transcriptomics Market (by Region), $Million, 2023, 2028, and 2034
Figure 3: Global Spatial Genomics and Transcriptomics Market (by Product Type), $Million, 2023, 2028, and 2034
Figure 4: Global Spatial Genomics and Transcriptomics Market (by Workflow), $Million, 2023, 2028, and 2034
Figure 5: Global Spatial Genomics and Transcriptomics Market (by Application), $Million, 2023, 2028, and 2034
Figure 6: Number of Patents in Spatial Genomics and Transcriptomics Market (by Country), January 2021-December 2024
Figure 7: Number of Patents in Spatial Genomics and Transcriptomics Market (by Year), January 2021-December 2024
Figure 8: Supply Chain Analysis: Global Spatial Genomics and Transcriptomics Market
Figure 9: Global Spatial Genomics and Transcriptomics Market, Value Chain Analysis
Figure 10: Advances in Spatial Transcriptomics
Figure 11: North America Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 12: U.S. Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 13: Canada Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 14: Europe Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 15: Germany Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 16: U.K. Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 17: France Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 18: Italy Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 19: Spain Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 20: Rest-of-Europe Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 21: Asia Pacific Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 22: China Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 23: Japan Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 24: India Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 25: Australia Spatial Genomics and Transcriptomics Market, 2022-2034
Figure 26: Singapore Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 27: Rest-of-Asia-Pacific Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 28: Latin America Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 29: Brazil Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 30: Mexico Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 31: Rest-of-Latin America Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 32: Middle East and Africa Spatial Genomics and Transcriptomics Market, $Million, 2022-2034
Figure 33: Synergistic Activities, January 2020- December 2024
Figure 34: Funding and Expansion, January 2020-December 2024
Figure 35: Product Launches (by Company), January 2021-September 2024
Figure 36: Data Triangulation
Figure 37: Top-Down and Bottom-Up Approach
Figure 38: Assumptions and Limitations

List of Tables
Table 1: Market Snapshot
Table 2: Global Spatial Genomics and Transcriptomics Market Opportunities
Table 3: Impact Analysis of Market Navigating Factors, 2022-2034
Table 4: Recent Funding in Spatial Genomics and Transcriptomics Market
Table 5: Cost Associated with Spatial Genomics and Transcriptomics Instruments
Table 6: Global Spatial Genomics and Transcriptomics Market (by Product Type), $Million, 2022-2034
Table 7: Global Spatial Genomics and Transcriptomics Market (by Kits and Assays), $Million, 2022-2034
Table 8: Global Spatial Genomics and Transcriptomics Market (by Instruments), $Million, 2022-2034
Table 9: Global Spatial Genomics and Transcriptomics Market (by Sample Type), $Million, 2022-2034
Table 10: Global Spatial Genomics and Transcriptomics Market (by Workflow), $Million, 2022-2034
Table 11: Global Spatial Genomics and Transcriptomics Market (by Spatial Imaging), $Million, 2022-2034
Table 12: Global Spatial Genomics and Transcriptomics Market (by Spatial Sequencing), $Million, 2022-2034
Table 13: Global Spatial Genomics and Transcriptomics Market (by Spatial Analysis), $Million, 2022-2034
Table 14: Global Spatial Genomics and Transcriptomics Market (by Application), $Million, 2022-2034
Table 15: Global Spatial Genomics and Transcriptomics Market (by Diagnostic), $Million, 2022-2034
Table 16: Global Spatial Genomics and Transcriptomics Market (by End User), $Million, 2022-2034
Table 17: Mergers and Acquisitions (by Company), January 2020-December 2024
Table 18: Funding Activities Share (by Company), January 2020-December 2024